Peripheral Blood WT1 Expression Refines Prognostic Information for MDS Patients Within the IPSS-R Risk Categories Very Low, Low and Intermediate. (April 2017) - Rautenberg, C.; Pechtel, S.; Geyh, S.; Jäger, P.; Haas, R.; Germing, U.; Kobbe, G.; Schroeder, T.